Every one of those 1 sits in a single category, earnings. Freightos is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each story carries 3 original sources on average, compared with 2.4 for the broader beat in this window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about GeneDx
Every one of those 1 sits in a single category, earnings. Freightos is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each story carries 3 original sources on average, compared with 2.4 for the broader beat in this window. Their average consequence score of 5 runs below the beat's 6.7 for that window. GeneDx appears in 1 tracked Finance story from February 21, 2026.
Stories tracked
1
Sources per story
3
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 74 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering GeneDx. Shared-story counts are live from our verified record — not editorial picks.
A trio of high-growth companies across genomics, biotechnology, and digital logistics are set to report quarterly results this Monday. Investors will be closely monitoring GeneDx's path to profitability, PepGen's clinical cash runway, and Freightos's transaction volume growth.
GeneDx is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.